Walleye Trading
BEAM icon

Walleye Trading’s Beam Therapeutics BEAM Stock Holding History

Walleye Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,800
Closed -$42.9K – 3984
2026
Q1 		$42.9K Sell
1,800
-6,000
-77% -$166K ﹤0.01% 3720
2025
Q4 		$216K Sell
7,800
-24,000
-75% -$612K ﹤0.01% 3345
2025
Q3 		$772K Buy
31,800
+23,700
+293% +$471K ﹤0.01% 2443
2025
Q2 		$138K Buy
+8,100
New +$141K ﹤0.01% 3445
2024
Q1 		– Sell
-27,400
Closed -$746K – 4764
2023
Q4 		$746K Buy
27,400
+4,100
+18% +$102K ﹤0.01% 2736
2023
Q3 		$560K Sell
23,300
-2,300
-9% -$61.7K ﹤0.01% 2861
2023
Q2 		$817K Buy
25,600
+8,300
+48% +$269K ﹤0.01% 2371
2023
Q1 		$530K Sell
17,300
-15,800
-48% -$624K ﹤0.01% 2748
2022
Q4 		$1.29M Buy
33,100
+1,100
+3% +$49.3K ﹤0.01% 2020
2022
Q3 		$1.52M Buy
32,000
+23,200
+264% +$1.32M ﹤0.01% 1918
2022
Q2 		$341K Buy
8,800
+4,900
+126% +$195K ﹤0.01% 3291
2022
Q1 		$223K Buy
+3,900
New +$256K ﹤0.01% 3696

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Walleye Trading's BEAM Position: Q2 2026 in Review

Walleye Trading sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 183 shares — an estimated $4.36K sold.

Walleye Trading first reported a position in BEAM in Q2 2022 and held it in 6 quarters. The position peaked at $508K in Q4 2022. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Walleye Trading reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 183 Beam Therapeutics shares in Q2 2026, an estimated $4.36K.
  • Walleye Trading first reported a position in Beam Therapeutics in Q2 2022 and held it in 6 quarters.
  • Walleye Trading's Beam Therapeutics position peaked at $508K in Q4 2022.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.